Icecure Medical Ltd. (ICCM) has disclosed a new risk, in the Share Price & Shareholder Rights category.
Icecure Medical Ltd. faces the risk of Nasdaq delisting if it fails to continuously meet the exchange’s listing requirements. Recently, the company was warned for not maintaining the minimum bid price but subsequently regained compliance. However, there is uncertainty regarding the future stability of the share price and sustained adherence to Nasdaq’s standards. Delisting could severely impact Icecure’s liquidity, shareholder trading capability, and access to further capital.
Overall, Wall Street has a Strong Buy consensus rating on ICCM stock based on 3 Buys.
To learn more about Icecure Medical Ltd.’s risk factors, click here.
